Press Releases

CAMBRIDGE, Mass., Oct. 29, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ:BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a Research and Development (R&D) Day for analysts and investors on Tuesday, November 5, 2

LEXINGTON, Mass., Oct. 29, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its third quarter financial results on Tuesday, November 5, 2019, after the close of US markets. Management w

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- Pasha Brands Ltd. ("Pasha") (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD). Between 2014 and 2018 global sales of legal cannabis more than tripled from $3.4 billion to $10.9 billion, according to the State of the Legal Cannabis Markets report from Arcvi

MISGAV, Israel, Oct. 29, 2019 /PRNewswire/ -- Gordian Surgical Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T; OTCQX: TRNLY), is pleased to announce that it has raised

HOUSTON, Oct. 29, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), discussed multiple additional indications that may be possible target

ALPHARETTA, Ga., Oct. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2019 on Tuesday, Nov. 5 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens th

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its third quarter 2019 financial results after market close on Tuesday, November 5, 2019.  Rigel senior management will follow the announcement with a live conference call and webcast at

HOUSTON, Oct. 29, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced the presentation of a poster at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference today in

CSE: CHOO OTCQB: CHOOF VANCOUVER, Oct. 29, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce that it has completed its acquisition of Clarity Cannabis' retail cannabis stores licensed and operating in the Province of Alberta. All 10 locations are now within Choom's corporate por

SAN BRUNO, Calif., Oct. 29, 2019 /PRNewswire/ -- Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades from both investors and attendees at the event, one of the year's biggest inv